MCT oil C8 vs C10 vs coconut oil: which fatty acid actually matters

← Back to articles

"MCT oil" is sold under several overlapping labels with very different fatty-acid profiles, and the differences are not cosmetic. Pure caprylic acid (C8) raises blood ketones the fastest and highest; capric acid (C10) is slower and milder; and coconut oil is dominated by lauric acid (C12), which behaves much more like an ordinary long-chain fat. If your reason for taking MCT is ketone production, the carbon-chain length on the label is the single most important variable, and it is the one marketing tends to blur.

Chain length defines the pharmacology

Medium-chain fatty acids have roughly 6 to 12 carbons. Unlike long-chain fats, they are largely absorbed directly into the portal circulation and delivered to the liver, where a portion is rapidly converted into the ketone bodies beta-hydroxybutyrate and acetoacetate—the brain's main physiological alternative fuel to glucose [1]. The clinical ketogenic literature is built specifically on the eight- and ten-carbon fatty acids octanoate (C8) and decanoate (C10); doses of roughly 20 to 70 g/day of these MCTs are what reliably induce a modest, transient nutritional ketosis [1]. C12 (lauric acid) is the odd one out: although technically a "medium" chain, in humans it is handled more like a long-chain fat, which is why coconut oil—despite the marketing—is a weak ketogenic agent.

Ketogenic response by fatty-acid type

The cleanest head-to-head comparison is an acute crossover study in nine healthy adults who, on separate days, took two 20-mL doses of different test oils—coconut oil, a classical C8/C10 MCT oil, pure C8, pure C10, and blends—with blood sampled every 30 minutes over eight hours [2]. Pure C8 was the most ketogenic by a wide margin, producing the largest area-under-the-curve ketone response of any oil tested. Coconut oil was weak: its plasma ketone peak reached only about 25% of the C8 peak [2]. In other words, the fatty acid that dominates coconut oil contributes little to ketosis, and the fatty acid that produces most of the effect (C8) is present in coconut oil only in small amounts. This is the empirical basis for choosing a C8-enriched product if ketones are the goal.

The cognition trials: a real but modest signal

The rationale for testing MCT oil in cognitive aging is that brain glucose uptake is impaired in Alzheimer disease while brain ketone uptake is relatively preserved, so supplying ketones might partly bypass the energy gap [1]. The evidence is genuine but limited. A randomized, double-blind, placebo-controlled trial of the caprylic-triglyceride product AC-1202 (marketed as Axona) in 152 patients with mild-to-moderate Alzheimer disease found significant improvements on the ADAS-Cog cognitive scale that were concentrated in participants who did not carry the APOE4 gene variant; the trial was industry-sponsored [3]. More recently, the 6-month BENEFIC randomized trial reported that a ketogenic MCT drink improved several cognitive measures in people with mild cognitive impairment compared with placebo [4]. Reviewers of this literature describe the overall effect on cognition as modest, and these products are not an approved or standard treatment—the use case remains promising rather than proven [1].

Why coconut oil is not the same product

By standard food-composition figures, coconut oil is roughly half lauric acid (C12) with substantial myristic (C14) acid and only a small fraction of true C8/C10 MCTs—the crossover study above characterized its coconut oil as about 3% C8 and 5% C10 [2]. Because lauric acid is handled largely like a long-chain fat, coconut oil is, for ketogenic purposes, best understood as a saturated cooking fat with a minor MCT component. It is a fine culinary oil; it is not a substitute for purified MCT oil if the aim is to raise ketones.

Tolerability and dosing

The main practical limit on MCT is the gut. Larger single doses, particularly of C8, commonly cause cramping, nausea, and diarrhea, which is why studies and supplement protocols emphasize starting low—on the order of a teaspoon—and titrating upward over one to two weeks, and why splitting the daily amount across meals improves tolerance and produces flatter ketone curves. Because ketosis from MCT is transient and dose-related, consistency and tolerability matter more than any single large dose.

Athletic performance: little support

Marketing of MCT for endurance and "clean energy" outruns the data. A longstanding sports-nutrition review concluded that ingesting the small amounts of MCT humans tolerate has no major effect on fat metabolism or exercise performance, and found insufficient evidence to recommend MCT for athletes [5]. A 2022 review of exogenous ketone strategies in athletes—which includes MCT—reached a similarly cautious conclusion, noting that many studies failed to show benefits of acute nutritional ketosis on performance or recovery [6]. The metabolic shift toward ketone fuel is real, but it has not translated into reliable performance gains.

Sources

1. Cunnane SC, Courchesne-Loyer A, St-Pierre V, et al. "Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease." Annals of the New York Academy of Sciences, 2016;1367(1):12-20. PMID 26766547.
2. Vandenberghe C, St-Pierre V, Pierotti T, et al. "Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults." Current Developments in Nutrition, 2017;1(4):e000257. PMID 29955698.
3. Henderson ST, Vogel JL, Barr LJ, et al. "Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial." Nutrition & Metabolism, 2009;6:31. PMID 19664276.
4. Cunnane SC, Sieber CC, Swerdlow RH, Cruz-Jentoft AJ. "Mild cognitive impairment: when nutrition helps brain energy rescue—a report from the EuGMS 2020 Congress." European Geriatric Medicine, 2021;12(6):1285-1292. PMID 34227053.
5. Hawley JA, Brouns F, Jeukendrup A. "Strategies to enhance fat utilisation during exercise." Sports Medicine, 1998;25(4):241-57. PMID 9587182.
6. Evans M, McClure TS, Koutnik AP, Egan B. "Exogenous Ketone Supplements in Athletic Contexts: Past, Present, and Future." Sports Medicine, 2022;52(Suppl 1):25-67. PMID 36214993.